On ECHEMI
Home > Drugs > Hepatitis D
Hepatitis D
Viral hepatitis type D is an acute and chronic liver inflammatory disease caused by hepatitis D virus (HDV) and hepatitis B virus and other hepatotropic DNA viruses. HDV is a defective virus, and it is rare to be infected with HDV alone. It can only exist in people infected with HBV and certain animals with positive surface antigen of hepatotropic DNA virus. The clinical manifestations of hepatitis D depend to a certain extent on the status of concurrent HBV infection. Over-infection of HDV and HBV can aggravate liver damage and easily develop into chronic active hepatitis, cirrhosis and severe hepatitis. Hepatitis D is mainly transmitted through blood transfusion and blood products, which is similar to the transmission mode of hepatitis B.
  • Site of disease:

    liver
  • Infectious :

    Contagious
  • Frequent population:

    HBV infection
  • Related symptoms:

    Intrahepatic HDAg is only transiently positive Diffuse liver lesions Fatigue Lack of appetite Fatigue
  • Concurrent disease:

Related Drugs
Ganyou Capsule
Manufacturer:

Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co., Ltd.

Yunzhigantai Capsules
Manufacturer:

Jiangsu Shenhua Pharmaceutical Co., Ltd.

Hepatocyte Growth Factor Injection
Indication: Used as adjuvant treatment for subacute severe hepatitis (early or mid-stage liver failure).
Manufacturer:

Weihai Sinogen Pharmaceutical Co., Ltd.

Matrine Sodium Chloride Injection
Indication: Mainly used for the treatment of chronic hepatitis B.
Manufacturer:

Jiangsu Huai'an Shuanghe Pharmaceutical Co., Ltd.

Hepatocyte Growth Factor for Injection
Indication: Used as an auxiliary treatment for various severe viral hepatitis (acute, subacute, early or middle stages of chronic severe hepatitis).
Matrine Glucose Injection
Indication: Used to restore alanine aminotransferase and bilirubin to normal in patients with chronic hepatitis.
Manufacturer:

Heilongjiang Yudi Pharmaceutical Co., Ltd.

Matrine Sodium Chloride Injection
Indication: Mainly used for the treatment of chronic hepatitis B.
Manufacturer:

Cisen Pharmaceutical Co., Ltd.

Diammonium Glycyrrhizinate Capsules
Indication: This product is suitable for the treatment of acute and chronic viral hepatitis accompanied by elevated alanine aminotransferase.
Manufacturer:

CHIA TAI Tianqing Pharmaceutical Group Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.